Eximia Research Network completes acquisition of Tidewater Clinical Research to expand its national clinical trial site network
Acquiring Company
Eximia Research Network
Acquired Company
Tidewater Clinical Research
Description
Eximia Research Network has successfully acquired Tidewater Clinical Research, a significant move in expanding its national clinical trial site network. The integration aims to enhance clinical research accessibility and quality of care for diverse patient populations by combining Tidewater's expertise and patient database with Eximia's extensive resources and experience.
Quick answer
Eximia Research Network is acquiring Tidewater Clinical Research, announced August 2, 2024. Eximia Research Network is based in Raleigh, North Carolina, United States.
- How much did Eximia Research Network pay for Tidewater Clinical Research?
- The deal value was not disclosed.
- What does Eximia Research Network do?
- Eximia Research is a national network of clinical trial sites with extensive clinical trial experience and resources.
- Where are Eximia Research Network and Tidewater Clinical Research based?
- Eximia Research Network is based in Raleigh, North Carolina, United States. Tidewater Clinical Research is based in Norfolk, Virginia, United States.
- Who are the decision-makers at Eximia Research Network?
- Fundz holds 3 contacts at Eximia Research Network. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- P95 completes acquisition of Assign DMB, expanding data management and biostatistics services (September 5, 2024)
- Becton, Dickinson and Company (BDX) completes acquisition of Critical Care from Edwards Lifesciences (September 3, 2024)
- ADVI Health completes acquisition of Partnership for Health Analytic Research to enhance Strategic Analytics, Value and Economics capabilities (August 23, 2024)
Who to call at Eximia Research Network, and when
When Eximia Research Network changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eximia Research Network raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eximia Research Network, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eximia Research Network. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eximia Research Network makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Tidewater Clinical Research?
Tidewater Clinical Research was acquired by Eximia Research Network, based in Raleigh. The deal was reported on August 2, 2024. Eximia Research is a national network of clinical trial sites with extensive clinical trial experience and resources. Eximia Research Network is privately held and operates in Biotechnology.
When did Eximia Research Network acquire Tidewater Clinical Research?
Eximia Research Network's acquisition of Tidewater Clinical Research was reported on August 2, 2024. Eximia Research Network has successfully acquired Tidewater Clinical Research, a significant move in expanding its national clinical trial site network. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Tidewater Clinical Research do?
Tidewater Clinical Research is a clinical research company with longstanding expertise in Women's Health and Ophthalmology in the Hampton Roads/Eastern Virginia region. It is privately held, operating in Biotechnology, and is based in Norfolk.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.